Literature DB >> 14557450

The mathematical model for total pubertal growth in idiopathic growth hormone (GH) deficiency suggests a moderate role of GH dose.

Michael B Ranke1, Anders Lindberg, David D Martin, Bert Bakker, Patrick Wilton, Kerstin Albertsson-Wikland, Chris T Cowell, David A Price, Edward O Reiter.   

Abstract

The role of GH treatment during total pubertal growth (TPG) is still unclear. We developed a prediction model for TPG (centimeters) through a multiple regression analysis of various prepubertal parameters in 303 adolescents with idiopathic GH deficiency from the KIGS database. Prepubertal catch-up growth and near-adult height were achieved, and GH dose was kept constant at approximately 30 micro g/kg.d. The model was validated on a cohort of 36 patients from one center. Four TPG predictors explained 70% of the variability with an error SD of 4.2 cm: gender (TPG in males was >11.3 cm vs. that in females), age at onset of puberty (negative), height SD score minus midparental height SD score at puberty onset (negative), and mean GH dose during puberty (positive). Our analysis suggests that TPG in idiopathic GH deficiency is only moderately dependent on GH dose. The use of a higher GH dosage at the onset of puberty should thus depend on the individual's height development. The TPG model aids in the planning of individually optimized and cost-effective GH treatment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14557450     DOI: 10.1210/jc.2003-030600

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  12 in total

Review 1.  Pediatric brain tumor treatment: growth consequences and their management.

Authors:  Sogol Mostoufi-Moab; Adda Grimberg
Journal:  Pediatr Endocrinol Rev       Date:  2010-09

Review 2.  Genetic causes and treatment of isolated growth hormone deficiency-an update.

Authors:  Kyriaki S Alatzoglou; Mehul T Dattani
Journal:  Nat Rev Endocrinol       Date:  2010-10       Impact factor: 43.330

3.  A mathematical model in the analysis of the response to growth hormone treatment in pediatric patients with diagnosis of growth hormone deficiency.

Authors:  G Migliaretti; P Berchialla; A Borraccino; D Gregori; F Cavallo
Journal:  J Endocrinol Invest       Date:  2012-02       Impact factor: 4.256

4.  Adult height in children with short stature and idiopathic delayed puberty after different management.

Authors:  Stefano Zucchini; Malgorzata Wasniewska; Mariangela Cisternino; Mariacarolina Salerno; Lorenzo Iughetti; Mohamad Maghnie; Maria Elisabeth Street; Manuela Caruso-Nicoletti; Stefano Cianfarani
Journal:  Eur J Pediatr       Date:  2007-08-24       Impact factor: 3.183

5.  Anastrozole increases predicted adult height of short adolescent males treated with growth hormone: a randomized, placebo-controlled, multicenter trial for one to three years.

Authors:  Nelly Mauras; Lilliam Gonzalez de Pijem; Helen Y Hsiang; Paul Desrosiers; Robert Rapaport; I David Schwartz; Karen Oerter Klein; Ravinder J Singh; Anna Miyamoto; Kim Bishop
Journal:  J Clin Endocrinol Metab       Date:  2007-12-28       Impact factor: 5.958

6.  Implications of a data-driven approach to treatment with growth hormone in children with growth hormone deficiency and Turner syndrome.

Authors:  Stefan Kaspers; Michael B Ranke; Donald Han; Jane Loftus; Hartmut Wollmann; Anders Lindberg; Mathieu Roelants; Joris Kleintjens
Journal:  Appl Health Econ Health Policy       Date:  2013-06       Impact factor: 2.561

7.  Corroboration of Height Velocity Prediction Markers for rhGH With an Oral GH Secretagogue Treatment in Children With GHD.

Authors:  Werner F Blum; George M Bright; Minh-Ha T Do; John C McKew; Haiying Chen; Michael O Thorner
Journal:  J Endocr Soc       Date:  2021-02-25

8.  Growth hormone (GH) dose-dependent IGF-I response relates to pubertal height gain.

Authors:  Elena Lundberg; Berit Kriström; Bjorn Jonsson; Kerstin Albertsson-Wikland
Journal:  BMC Endocr Disord       Date:  2015-12-18       Impact factor: 2.763

Review 9.  Aromatase inhibitors for short stature in male children and adolescents.

Authors:  Niamh McGrath; Michael J O'Grady
Journal:  Cochrane Database Syst Rev       Date:  2015-10-08

10.  Pre-treatment growth and IGF-I deficiency as main predictors of response to growth hormone therapy in neural models.

Authors:  Urszula Smyczyńska; Joanna Smyczyńska; Maciej Hilczer; Renata Stawerska; Ryszard Tadeusiewicz; Andrzej Lewiński
Journal:  Endocr Connect       Date:  2017-12-14       Impact factor: 3.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.